维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="CONCOLINO P"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Rapid UGT1A1 (TA)(n) genotyping by high resolution melting curve analysis for Gilbert's syndrome diagnosis显示文摘	Minucci A Concolino P Giardina B		0，，3：	1
2	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistancein ovarian cancer patients显示文摘	Mozzet ti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
3	Class I11 beta-tubulin overex- pression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
4	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
5	Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
6	Class Ⅲβ-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
7	Class Ⅲ beta-tubulin over expression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	MOZZETTI S FERLINI C CONCOLINO P	2005	Clin Cancer Res2005，11，1：	1
8	Class Ⅲ betatubulin overexpression is a prominent mechanism of paditaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
9	Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
10	Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase de- ficiency: an update of new CYP21 A2 mutations 显示文摘	Concolino P Mello E Zuppi C	2010	Clin Chem Lab Med2010，48，：	1
11	A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form显示文摘	Concolino P Mello E Minucci A	2009	BMC Med Genet2009，10，：	1
12	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
13	Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
14	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
15	Class Ⅲ beta-tubulin over-expression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
16	Genetic analysis of the dystroglycan gene in bronchopulmonary dysplasia affected premature newboms显示文摘	Concolino P Capoluongo E Santonocito C	2007	Clin Chim Acta2007，378，112：	1
17	A novel MEN1 frameshift gerrnline mutation in two Italian monozygotic twins显示文摘	Concolino P Rossodivita A Carrozza C	2008	Clin Chem Lab Med2008，46，8：	1
18	Multiplex ligation- dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in congenital adrenal hyperplasia :first technical report显示文摘	Concolino P Mello E Toscano V	2009	Clin Chim Acta2009，402，12：	1
19	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzelti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
20	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示